Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 50

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Germline Variants That Affect Tumor Progression

Chatrath, Ajay, Ratan, Aakrosh, Dutta, Anindya·2021·Trends in Genetics
DOI 10.1016/j.tig.2020.10.005PMC PMC8043969
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tig.2020.10.005

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 47

  1. Huang, 2018, Pathogenic germline variants in 10,389 adult cancers, Cell, 173, 355, 10.1016/j.cell.2018.03.039 · DOI
  2. Berger, 2018, The emerging clinical relevance of genomics in cancer medicine, Nat. Rev. Clin. Oncol., 15, 353, 10.1038/s41571-018-0002-6 · DOI
  3. Chirita-Emandi, 2020, Challenges in reporting pathogenic/potentially pathogenic variants in 94 cancer predisposing genes - in pediatric patients screened with NGS panels, Sci. Rep., 10, 223, 10.1038/s41598-019-57080-9 · DOI
  4. Sud, 2017, Genome-wide association studies of cancer: current insights and future perspectives, Nat. Rev. Cancer, 17, 692, 10.1038/nrc.2017.82 · DOI
  5. Li, 2017, Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists, J. Mol. Diagn., 19, 4, 10.1016/j.jmoldx.2016.10.002 · DOI
  6. Bodmer, 2010, Rare genetic variants and the risk of cancer, Curr. Opin. Genet. Dev., 20, 262, 10.1016/j.gde.2010.04.016 · DOI
  7. Zhao, 2014, The Bim deletion polymorphism clinical profile and its relation with tyrosine kinase inhibitor resistance in Chinese patients with non-small cell lung cancer, Cancer, 120, 2299, 10.1002/cncr.28725 · DOI
  8. Tomasetti, 2015, Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions, Science, 347, 78, 10.1126/science.1260825 · DOI · Paper page
  9. Carter, 2017, Interaction landscape of inherited polymorphisms with somatic events in cancer, Cancer Discov., 7, 410, 10.1158/2159-8290.CD-16-1045 · DOI
  10. Rahman, 2014, Realizing the promise of cancer predisposition genes, Nature, 505, 302, 10.1038/nature12981 · DOI
  11. Berger, 2011, A continuum model for tumour suppression, Nature, 476, 163, 10.1038/nature10275 · DOI
  12. Kanchi, 2014, Integrated analysis of germline and somatic variants in ovarian cancer, Nat. Commun., 5, 3156, 10.1038/ncomms4156 · DOI
  13. Jones, 2009, JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms, Nat. Genet., 41, 446, 10.1038/ng.334 · DOI
  14. Kilpivaara, 2009, A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms, Nat. Genet., 41, 455, 10.1038/ng.342 · DOI
  15. Campbell, 2009, Somatic and germline genetics at the JAK2 locus, Nat. Genet., 41, 385, 10.1038/ng0409-385 · DOI
  16. Olcaydu, 2009, A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms, Nat. Genet., 41, 450, 10.1038/ng.341 · DOI
  17. Liu, 2011, Functional EGFR germline polymorphisms may confer risk for EGFR somatic mutations in non-small cell lung cancer, with a predominant effect on exon 19 microdeletions, Cancer Res., 71, 2423, 10.1158/0008-5472.CAN-10-2689 · DOI
  18. Mamidi, 2019, Mapping the germline and somatic mutation interaction landscape in indolent and aggressive prostate cancers, J. Oncol., 2019, 4168784, 10.1155/2019/4168784 · DOI
  19. Yu, 2018, Integrated case-control and somatic-germline interaction analyses of melanoma susceptibility genes, Biochim. Biophys. Acta Mol. Basis Dis., 1864, 2247, 10.1016/j.bbadis.2018.01.007 · DOI
  20. Ramroop, 2019, Germline variants impact somatic events during tumorigenesis, Trends Genet., 35, 515, 10.1016/j.tig.2019.04.005 · DOI
  21. Chatrath, 2019, The germline variants rs61757955 and rs34988193 are predictive of survival in lower grade glioma patients, Mol. Cancer Res., 17, 1075, 10.1158/1541-7786.MCR-18-0996 · DOI
  22. Relling, 2015, Pharmacogenomics in the clinic, Nature, 526, 343, 10.1038/nature15817 · DOI
  23. Weinshilboum, 2017, Pharmacogenomics: precision medicine and drug response, Mayo Clin. Proc., 92, 1711, 10.1016/j.mayocp.2017.09.001 · DOI
  24. Daly, 2017, Pharmacogenetics: a general review on progress to date, Br. Med. Bull., 124, 65
  25. Romero Lagunes, 2019, Design and implementing pharmacogenomics study in cancer, Adv. Exp. Med. Biol., 1168, 43, 10.1007/978-3-030-24100-1_4 · DOI
  26. Tate, 2019, COSMIC: the Catalogue Of Somatic Mutations In Cancer, Nucleic Acids Res., 47, D941, 10.1093/nar/gky1015 · DOI · Paper page
  27. Battaglin, 2018, Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives, Clin. Adv. Hematol. Oncol., 16, 735
  28. Duffy, 2019, Biomarkers for predicting response to immunotherapy with immune checkpoint inhibitors in cancer patients, Clin. Chem., 65, 1228, 10.1373/clinchem.2019.303644 · DOI
  29. Arora, 2019, Existing and emerging biomarkers for immune checkpoint immunotherapy in solid tumors, Adv. Ther., 36, 2638, 10.1007/s12325-019-01051-z · DOI
  30. Summers, 2020, Comprehensive analysis of colorectal cancer-risk loci and survival outcome: a prognostic role for CDH1 variants, Eur. J. Cancer, 124, 56, 10.1016/j.ejca.2019.09.024 · DOI
  31. Marasigan, 2019, Melanoma susceptibility variant rs869330 in the MTAP gene is associated with melanoma outcome, Melanoma Res., 29, 590, 10.1097/CMR.0000000000000578 · DOI
  32. Shu, 2018, Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome, Carcinogenesis, 39, 752, 10.1093/carcin/bgy021 · DOI
  33. Stotz, 2017, Cancer stem cell gene variants in CD44 predict outcome in stage II and stage III colon cancer patients, Anticancer Res., 37, 2011, 10.21873/anticanres.11545 · DOI
  34. Świerniak, 2016, Association between GWAS-derived rs966423 genetic variant and overall mortality in patients with differentiated thyroid cancer, Clin. Cancer Res., 22, 1111, 10.1158/1078-0432.CCR-15-1746 · DOI
  35. Koessler, 2009, Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer, Int. J. Cancer, 124, 1887, 10.1002/ijc.24120 · DOI
  36. Mosquera Orgueira, 2019, The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution, BMC Cancer, 19, 515, 10.1186/s12885-019-5628-y · DOI
  37. Macauda, 2018, Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients, Br. J. Haematol., 183, 375, 10.1111/bjh.15521 · DOI
  38. Chatrath, 2020, The pan-cancer landscape of prognostic germline variants in 10,582 patients, Genome Med., 12, 15, 10.1186/s13073-020-0718-7 · DOI
  39. 2013, Nat. Genet., 45, 580, 10.1038/ng.2653 · DOI · Paper page
  40. Zhang, 2019, The cancer-associated genetic variant rs3903072 modulates immune cells in the tumor microenvironment, Front. Genet., 10, 754, 10.3389/fgene.2019.00754 · DOI
  41. Le Page, 2019, Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: a systematic review and case report analysis, Gynecol. Oncol., 156, 377, 10.1016/j.ygyno.2019.11.019 · DOI
  42. Musa, 2019, Cooperation of cancer drivers with regulatory germline variants shapes clinical outcomes, Nat. Commun., 10, 4128, 10.1038/s41467-019-12071-2 · DOI
  43. Mastorakos, 2019, Tumor to cerebellar peduncle T2-weighted imaging intensity ratio fails to predict pituitary adenoma consistency, J. Neurol. Surg. B Skull Base, 80, 252, 10.1055/s-0038-1668516 · DOI
  44. Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 · DOI · Paper page
  45. Lu, 2015, Patterns and functional implications of rare germline variants across 12 cancer types, Nat. Commun., 6, 10086, 10.1038/ncomms10086 · DOI
  46. Abana, 2017, IL-6 variant is associated with metastasis in breast cancer patients, PLoS One, 12, 10.1371/journal.pone.0181725 · DOI
  47. Lim, 2018, Germline genetic polymorphisms influence tumor gene expression and immune cell infiltration, Proc. Natl. Acad. Sci. U. S. A., 115, E11701, 10.1073/pnas.1804506115 · DOI

Cited by

Metadata

Authors
Chatrath, A., Ratan, A., & Dutta, A.
Venue
Trends in Genetics
Publisher
Elsevier BV
Published
2021-05
Volume
37
Issue
5
Pages
433-443
ISSN
0168-9525
DOI
10.1016/j.tig.2020.10.005
PMC
PMC8043969
Cited by
50
References
5
Language
en
Licence
Funders
National Institutes of Health

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review